The largest database of trusted experimental protocols

98 protocols using fk506

1

Astrocyte Conditioned Media Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
After reaching 90–95% confluence, astrocyte monolayers were washed with PBS, incubated with serum-free Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc.) for 24 h to allow cells to reach a non-dividing G0-phase in the cell cycle (14 (link)), then treated with or without 20 µM FK506 (Sigma-Aldrich) in serum-free DMEM for 24 h. The conditioned media (CM) of the control group (C-CM) and FK506-treated group (FK506-CM) were collected, centrifuged at 7,500 × g for 20 min by an Amicon Ultra-4 3K centrifugal filter device (Merck Millipore) to remove residual FK506, then diluted to the initial volume with neurobasal medium (Gibco; Thermo Fisher Scientific, Inc., Grand Island, NY, USA). Subsequently, the conditioned media were stored at −80°C and used within one week.
+ Open protocol
+ Expand
2

Investigating FXR Role in Tacrolimus-Induced Diabetes

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test if the FXR is involved in tacrolimus-induced diabetes mellitus, we purchased human renal cortex proximal tubule epithelial (HK-2) cell lines (Stem Cell Bank of the Chinese Academy of Sciences, No. CRL-2190TM) and divided them into three groups: (1) the control group: HK-2 cells were cultured routinely with dimethyl sulphoxide (DMSO) solution (Sigma-Aldrich, USA, No. 34869-100ML); (2) the FK506 group: HK-2 cells were treated with 15 µmol/L FK506 (Sigma-Aldrich, USA, No. F4679) for 24, 48 and 72 h; and (3) the GW4064 group: HK-2 cells were treated with 4 μmol/L GW4064 for 24, 48 and 72 h. We collected all cell samples for mRNA and protein detection.
+ Open protocol
+ Expand
3

T Cell Activation Regulation by Pharmacological Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells and total T cells were isolated from single cell suspensions of spleens and lymph nodes by negative separation using a mouse CD4+ T cell or a total T cell Enrichment kit (both STEMCELL Technologies). T cells were stimulated in RPMI 1640 medium (supplemented with 10% FBS, 2 mM L-glutamine, 50 mM 2-mercaptoethanol and 100 U/ml penicillin plus streptomycin; all Cellgro) with 1 μg/ml plate-bound anti-CD3 (clone 2C11) plus 1 μg/ml anti-CD28 Abs (clone 37.51, both BioXCess) in the presence or absence of 1 μM FK506 (Sigma Aldrich), 10 mM 2-DG (Sigma Aldrich), 5 ng/ml IL-7 (Peprotech), 50 U/ml IL-2 (Peprotech) or left unstimulated as indicated. PBMCs from individuals homozygous (patient) and heterozygous (mother) for a STIM1 p.L374P mutation were isolated from blood samples by density centrifugation using Ficoll-Paque plus (GE Amersham). Human CD4+ T cells were isolated using CD4 MicroBeads (Miltenyi Biotec). PBMCs or purified T cells were stimulated with 1 μg/ml plate-bound anti-CD3 (clone OKT3) and 1 μg/ml anti-CD28 (clone CD28.2, both eBioscience) monoclonal antibodies in the presence or absence of 1 μM FK506 (Sigma Aldrich) or 500 nM BTP2 (Sigma Aldrich) or left unstimulated as indicated.
+ Open protocol
+ Expand
4

Evaluating Cell Death Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
DAPI (4 ,6-diamidino-2-phenylindole, Cat No. D9592), propidium iodide (PI, Cat No. P4170), staurosporine (Cat No. S6942) and FK506 (tacrolimus, Cat No. F4679) were purchased from Sigma-Aldrich (Bornem, Belgium). FTI-277 was a kind gift from Janssen Pharmaceutica (Beerse, Belgium). 1 mg/ml stock solutions of PI (40×) and DAPI (10,000×) were made in H 2 O. staurosporine and FTI-277 were dissolved in DMSO (Sigma-Aldrich, Cat No. 276855) in a stock solution of 1 mM. FK506 was dissolved in DMSO in a stock solution of 10 mM (1000×). For Western blot the antihuman anti-␣-SYN antibody 15G7 (1:100, Enzo Life Sciences, Cat No. ALX-804-258) was used and a mouse monoclonal anti-␣tubulin antibody (1:50,000, Sigma, Cat No. T5168) was used as internal loading control. The rabbit polyclonal antibody against cleaved caspase-3 was purchased from Cell Signaling Technology (Danvers, MA, USA Cat No. 9661s), and used at 1:500 and 1:1000 for immunocytochemistry (ICC) and western blotting, respectively. The cytotoxicity detection kit was purchased from Roche (Cat No. 11644793001 ) and the lactate dehydrogenase activity was determined according to the manufacturer's instructions.
+ Open protocol
+ Expand
5

Synthetic Aβ Oligomers: A Tractable Tool for Alzheimer's Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length, synthetic Aβ 1–42 peptides (AβOs; American Peptide, Sunnyvale, CA) were prepared exactly according to the method of Lambert et al. (1998) (link) and applied to 11–13 DIV cells at a final concentration of 500 nM for 18 h. We use synthetic AβOs in our studies for the following reasons. First, they mimic the toxic properties of natural oligomers (brain or cell derived) as described previously (Jin et al., 2011 (link); Welzel et al., 2014 (link)). Second, unlike natural oligomers, synthetic AβOs can be detected by immunocytochemistry. Confirmation of AβO binding is crucial in our experiments because it varies considerably between neurons. Although they may not be identical to natural oligomers, synthetic AβOs are a tractable tool for investigating mechanisms of AD pathogenesis (Ferreira and Klein, 2011 (link)). After AβO or vehicle exposure, cells were incubated with 1 μM FK506 (Sigma-Aldrich, St. Louis, MO) or equivalent volumes of vehicle (ethanol) for 1–3 h before imaging of transport. For all VGCC inhibition experiments, cells were incubated with 100 μM conotoxin GVIA (Alomone Labs, Jerusalem, Israel), 50 μM agatoxin IVA (Alomone Labs), or 10 μM nimodipine (Tocris Bioscience, Bristol, United Kingdom) for 30 min before AβO treatments. For all RyR inhibition experiments, cells were incubated with 0.5 μM dantrolene (Sigma-Aldrich) for 1 h before AβO treatment.
+ Open protocol
+ Expand
6

Pharmacological Inhibitors for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
SB202190, GSK2606414, thapsigargin (Tg), FK506, chloroquine (CQ), and cyclosporin A (CsA) were purchased from Sigma-Aldrich (St Louis, MO, USA). Torin 1 was from (Tocris-Biotechne, Minneapolis, MN, USA).
+ Open protocol
+ Expand
7

OT-I Rag−/− Splenocyte Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes from OT-I Rag−/− mice (and the genetic variants) were stimulated ex-vivo with recombinant peptide (N4, T4, or G4) at the indicated doses for 24h. Antigen-presenting-cells (APCs) in the bulk splenocyte population were sufficient for stimulation. (Figures 12) Recombinant peptides were purchased from 21st Century Biochemicals (Marborough, MA). PRN694 was generously provided by Principia Pharmaceuticals (19 (link)). For stimulation readouts earlier than 24h, OT-I T cells were stimulated at a 5:1 ratio of APCs to T cells. The APCs used were bulk splenocytes isolated from WT C57BL/6 mice, then pulsed with peptide prior to the addition of T cells. (Fig. 4) APCs used in Fig. 5 were stimulated with LPS (1ug/mL) and pulsed with peptide for 1h prior to addition of T cells. LPS, FK506, PMA, and Ionomycin were purchased from Sigma-Aldrich (St. Louis, MO). Fractionated CD8 T cells used in Fig. S3CD were stimulated with 1µg/mL of plate-bound αCD3ε antibody (Clone 1742) purchased from Biolegend for 12-36h.
+ Open protocol
+ Expand
8

Chemical Inhibitors of Cell Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
BEZ235, CAL-101, GSK650394, Roscovitine, Salubrinal, AZD8055, MK-2206 and PF4708671 were from Selleck Chemicals LLC (Houston, TX, USA). CN585 (6-(3,4-Dichlorophenyl)-4-(N,N-dimethylaminoethylthio)-2-phenyl-pyrimidine) was from Merck Millipore (Merck, Damstadt, Germany). Ionomycin, PMA, CsA, FK-506 and BV-02 were from Sigma-Aldrich.
+ Open protocol
+ Expand
9

Zebrafish Tremblor Mutant Cardiac Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zebrafish tremblor tc318 heterozygotes were bred in the Tg(myl7:EGFP) background and raised as previously described (Westerfield, 2000 ). Embryos were raised at 28.5°C and staged as previously described (Kimmel et al., 1995 (link)). For Cn or proteasome inhibition, embryos were treated with 10 μM FK506 (Sigma-Aldrich, St. Louis, MO) or 50 μM MG132 (Sigma-Aldrich) at 24 hpf. The morpholino-modified antisense oligonucleotides targeting the translation initiation sites of murf1a and murf1b (Table 1, Gene Tools) were microinjected at the 1- to 2 cell stage (8 ng each). This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the University of California, Los Angeles. The protocol was approved by the Chancellor's Animal Research Committee of the University of California, Los Angeles.
+ Open protocol
+ Expand
10

Osteogenic Differentiation of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells at passage 3 with 80% confluence were trypsinized using TrypLE Express and seeded into six plates at 1×104 cells/cm2 and incubated with Mesenchymal Stem Cell Growth medium at 37°C for 24 h. Following incubation, the growth medium was replaced with 2 ml osteo-induction medium was prepared as previously described (12 (link)) containing 10 mM Na β-glycerophosphate (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), 0.25 mM l-ascorbic acid (MP Biomedicals, LLC, Santa Ana, CA, USA) and 0, 5, 50, 500 or 5,000 nM FK506 (Sigma-Aldrich; Merck KGaA). The osteo-induction medium was replaced every other day; cells were collected at 3, 7 and 14 days for RT-qPCR analysis, and phenotype staining was done at 7 or 14 days. All biochemical assays were carried out at least three times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!